Spain’s AEMPS Suspends Manufacturing in Madrid Facility By Sam | February 3, 2017 Spain’s medicines and medical devices agency suspended manufacturing at Euro Far Alergi’s Madrid facility citing serious GMP violations. Source: Drug Industry Daily Posted in Drug Industry Daily